Showing results (111-120 of 190) with videos related to
Sort By:
Pageof 19
Spine|October 30, 2010
Predicting the outcome of selective thoracic fusion in false double major lumbar "C" cases with five- to twenty-four-year follow-upMichael S Chang, Keith H Bridwell, Lawrence G Lenke, et al.Clinical Breast Cancer|October 28, 2004
Survival benefit with capecitabine/docetaxel versus docetaxel alone: analysis of therapy in a randomized phase III trialDavid Miles, Svetislava Vukelja, Vladimir Moiseyenko, et al.Breast Cancer Research and Treatment|May 22, 2009
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancerJohn W Smith, Kristi J McIntyre, Patrick V Acevedo, et al.Early Pregnancy : Biology and Medicine : the Official Journal of the Society for the Investigation of Early Pregnancy|March 23, 1999
11 beta-Hydroxysteroid dehydrogenase enzyme activity in granulosa cells derived from ovarian follicles of in vitro fertilization patientsA O'Shaughnessy, O Muneyyirci-Delale, V L Nacharaju, et al.Spine Deformity|December 9, 2016
Predicting Kyphosis Correction During Posterior-Only Vertebral Column Resection by the Amount of Spinal Column ShorteningWoojin Cho, Lawrence G Lenke, Kathy M Blanke, et al.Cancer Research|June 1, 1993
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factorS L Berg, D M Savarese, F M Balis, et al.Molecular Cancer Therapeutics|October 12, 2018
A Four-gene Decision Tree Signature Classification of Triple-negative Breast Cancer: Implications for Targeted TherapeuticsJelmar Quist, Hasan Mirza, Maggie C U Cheang, et al.Journal of Neurosurgery. Spine|September 6, 2011
Morbidity and mortality after spinal deformity surgery in patients 75 years and older: complications and predictive factorsFrank L Acosta, Jamal McClendon, Brian A O'Shaughnessy, et al.Anticancer Research|July 18, 2008
Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patientsZhibao Mi, Frankie A Holmes, Beth Hellerstedt, et al.Clinical Breast Cancer|March 28, 2007
Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapyJoanne L Blum, E Claire Dees, Svetislava J Vukelja, et al.Pageof 19